The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions
Open accessAbstract
had no impact on blood counts or indices. Mutational burden of both genes correlated with X-inactivation skewing but no significant association with age-adjusted telomere length reduction was documented. The discordance between the high prevalence of mutations in these 2 genes and their limited biological impact raise the question of the potential role of dysregulated epigenetic modifiers in normal aging hematopoiesis, which may include support to failing hematopoiesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other studies have found links between CHIP and chronic obstructive pulmonary disease (COPD) 37,63.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various other systemic effects have been described in association with CH, including chronic obstructive pulmonary disease and other pulmonary disease [16,33,34]”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function heterozygous mutations in epigenetic regulators DNMT3A (cytosine methyltransferase) and TET2 (methylcytosine dioxygenase) are the most frequently detected mutations in CHIP, accounting for about 50% to 60% and 10% to 30% of mutations found in CHIP carriers, respectively.1, 2, 3,7,8”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of CHIP, TET2 mutations show highest clonal expansion rates over time (with an estimated 10% annual growth rate compared with 5% of DNMT3A mutations7,8,10).”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function heterozygous mutations in epigenetic regulators DNMT3A (cytosine methyltransferase) and TET2 (methylcytosine dioxygenase) are the most frequently detected mutations in CHIP, accounting for about 50% to 60% and 10% to 30% of mutations found in CHIP carriers, respectively.1, 2, 3,7,8”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“are predicted to have high expansion rates (10% increase in mean VAF per year1, 2, 3,7)”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“many have noted that DNMT3A mutations confer little phenotype on steady state hematopoiesis (Buscarlet et al., 2017)”
From Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling (2021) · cites this paper as Buscarlet et al., 2017
In the citing paper
“CHIP itself does not denote a malignancy, nor is it associated with clinically significant alterations in blood counts 28,63.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
In the citing paper
“However, CHIP was also strongly linked to smoking in these studies, so the result could be confounded by this association.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Telomere measurement by quantitative PCR
Cawthon, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,550
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Cited by
Sorted by citations
Items 301–381 of 381
Rogges, E., Pelliccia, S., Lopez, G., Barresi, S., Tafuri, A., Alaggio, R., & Napoli, A. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169349 · Cited by 3
Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer
Zuriaga, M. A., & Fuster, J. J. (2023) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2023.02.004 · Cited by 3
A Mutational Landscape in Acute Myeloid Leukemia: Overview and Prognostic Impacts
Chen, J., Hassan, F., & Tirado, C. A. (2025) · Diagnostics · doi:10.3390/diagnostics15192537 · Cited by 2
Clonal haematopoiesis of indeterminate potential and risk of incident psychiatric disorders
Yu, Y., Wan, C., Li, J., Sun, Y., Yu, B., Tan, X., Wang, B., Lu, Y., & Wang, N. (2026) · BMC Medicine · doi:10.1186/s12916-026-04720-3 · Cited by 2
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution
Civettini, I., Malighetti, F., Villa, M., Crippa, V., Aroldi, A., Cavalca, F., Graudenzi, A., Lanino, L., Maggioni, G., Haferlach, T., et al. (2026) · NEJM Evidence · doi:10.1056/evidoa2500124 · Cited by 2
Understanding Human Oncogene Function and Cooperativity in Myeloid Malignancy Using iPSCs
Sarchi, M., & Doulatov, S. R. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104697 · Cited by 2
Id1 promotes clonal hematopoiesis in mice with Tet2 loss of function
Singh, S., Gudmundsson, K. O., Sarkar, T., Jakubison, B. L., Morris, H. M., Burkett, S. S., Karim, B. O., Pauly, G. T., Sigano, D. M., Schneider, J. P., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr5867 · Cited by 4
Eadie, L. N., Rehn, J. A., Schutz, C. E., Heatley, S. L., Kutyna, M., Hiwase, D., White, D. L., & Yeung, D. T. O. (2023) · British Journal of Haematology · doi:10.1111/bjh.19008 · Cited by 2
Tumour tamed by transfer of one T cell
Maus, M. V. (2018) · Nature · doi:10.1038/d41586-018-05251-5 · Cited by 2
Bagacean, C., Bordron, A., Tempescul, A., Ianotto, J., Guillerm, G., Brooks, W. H., Couturier, M., Zdrenghea, M., Berthou, C., & Renaudineau, Y. (2018) · OBM Genetics · doi:10.21926/obm.genet.1804054 · Cited by 2
Update on Clonal Hematopoiesis
Bolton, K. L. (2021) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/s2152-2650(21)01199-x · Cited by 2
Yu, X., Qian, N., & Wang, Y. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08118-1 · Cited by 2
The Medical Genome Reference Bank: Whole genomes and phenotype of 2,570 healthy elderlyPreprint
Pinese, M., Lacaze, P. A., Rath, E. M., Stone, A. M., Brion, M., Ameur, A., Nagpal, S., Puttick, C., Husson, S., Degrave, D., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/473348 · Cited by 2
McClatchy, J., Strogantsev, R., Wolfe, E., Lin, H., Mohammadhosseini, M., Davis, B. A., Eden, C. O., Goldman, D., Fleming, W., Conley, P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.15.507688 · Cited by 2
Dose-dependent effects of Dnmt3a in an inducible murine model of Kras-driven leukemia
Rogers, J. H., Rosen, A., Reyes, J. M., Ketkar, S., Conneely, S. E., Gupta, R., Yang, L., Miller, M. B., Medrano, G., Aguilar, R., et al. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104248 · Cited by 1
Healthy lifestyle attenuates the clonal hematopoiesis-associated coronary artery disease risk
Yang, Y., Shen, X., Huang, K., Liu, H., Li, J., Liu, F., Chen, S., Cao, J., Li, H., Liu, X., et al. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.09.012 · Cited by 1
Verma, D., Zeig‐Owens, R., Goldfarb, D. G., Kravets, L., Pradhan, K., Rockwell, B., Sahu, S., Kelly, S., Giricz, O., Jasra, S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1590 · Cited by 2
Elucidating the risk factors and oncogene drivers of acute myeloid leukemia
Sanya, D. R. A., & Onésime, D. (2025) · Human Cell · doi:10.1007/s13577-025-01294-9 · Cited by 1
Wang, L., Chien, W., Sheng‐Kai, K., Chung, C., Chen, Y., Tsai, W.-C., & Yang, B.-H. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004646 · Cited by 1
Cancer‐Like Fragmentomic Characteristics of Somatic Variants in Cell‐Free DNA
Zhang, Z., An, Y., Yang, M., Pan, Y., Liu, X., Gong, F., Lin, H., Tang, B., Wang, W., Bai, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202514819 · Cited by 1
Ageing Through the Looking‐Glass: The Different Flavours of Clonal Haematopoiesis
Singh, J., Curtis, D. J., Thảo, L. T. P., Wood, E. M., & McQuilten, Z. (2026) · Aging Cell · doi:10.1111/acel.70425 · Cited by 1
Ma, X., Yang, C. H., Duan, Y., Zhang, H., Tang, X., Zhang, Q., Qin, W., Zhang, W., Tang, G., Guan, M., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1771587 · Cited by 1
Aging of hematopoietic stem cells is inconsequential to progenitor cell function
Myers, J., Worthington, A. K., Poscablo, D. M., Medina, P., Chattopadhyaya, S., Mogharrab, R., Rommel, M. G. E., & Forsberg, E. C. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102965 · Cited by 3
Chen, S., Chen, H.-W., Chu, C. H., Hsu, P., Yu, Y.-S., Lin, S., Wu, Y.-X., Lin, E. C., Lin, T.-A., Chen, M.-H., et al. (2026) · Mitochondrion · doi:10.1016/j.mito.2026.102192 · Cited by 1
Al-Ansari, R. Y., Otaibi, D. A., Hudaithi, N. A., & Abdalla, L. (2021) · SAGE Open Medical Case Reports · doi:10.1177/2050313x211032066 · Cited by 1
Evolutionary perspectives on cancer and aging
Bodmer, W. F., & Crouch, D. J. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90752-1.00008-0 · Cited by 1
Klonale Hämatopoese – Ursachen und klinische Implikationen
Burchert, A. (2023) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-023-02162-7 · Cited by 1
Methods for Estimating Personal Disease Risk and Phylogenetic Diversity of Hematopoietic Stem Cells
Craig, J. M., Gerhard, G. S., Sharma, S., Yankovskiy, A., Miura, S., & Kumar, S. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad279 · Cited by 1
Li, J., Qi, Z., Xu, Y., Cao, Y., Li, Y., & Han, Y. (2024) · Cardiology Discovery · doi:10.1097/cd9.0000000000000139 · Cited by 1
Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformation
Lawrence, E., Cooray, A., Kueh, A. J., Pál, M., Tai, L., Garnham, A. L., Suen, C. S. N. L. W., Vanyai, H. K., Gouil, Q. A., Lancaster, J., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00450-4 · Cited by 1
Krishnan, A., Miles, L. A., & Challen, G. A. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104816 · Cited by 1
Relevance of Clonal Hematopoiesis in Immune Cells for Degenerative Aortic Valve Stenosis
Mas‐Peiró, S., Dimmeler, S., & Zeiher, A. M. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.044406 · Cited by 1
Bedeutung der klonalen Hämatopoese für hämatologische Neoplasien
Götze, K. S. S., & Lengerke, C. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01401-0 · Cited by 1
Gillis, N., Moscinski, L. C., & Padron, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-44870-1_57-1 · Cited by 1
González‐Gil, C., Morgades, M., Lopes, T., Fuster‐Tormo, F., García-Chica, J., Zhao, R., Montesinos, P., Torrent, A., Díaz‐Beyá, M., Coll, R., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4068248 · Cited by 1
Dawoud, A. A. Z., Tapper, W., & Cross, N. C. P. (2022) · medRxiv · doi:10.1101/2022.09.05.22279615 · Cited by 1
Páramo, J. A. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.04.007
Páramo, J. A. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.07.006
Clonal Hematopoiesis and Cytopenias in the Elderly
Guy, D. G., Afzal, A., & Jacoby, M. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-96487-4_12
Genetics and Pharmacogenetics of COPD
Bossé, Y., & Cho, M. H. (2020) · Respiratory medicine · doi:10.1007/978-3-030-31507-8_4
A view from the hospital window.
Richards, A. G. (1974) · PubMed
Проблемы при реализации креативного менеджмента в организации
Цыганкова, В. Н. (2010) · Креативная экономика
Murakami, K., Yamaguchi, Y., Kida, Y., Morikawa, Y., Ujiie, H., Sugahara, H., Nannya, Y., Ogawa, S., & Kanakura, Y. (2021) · Internal Medicine · doi:10.2169/internalmedicine.7571-21
Афанасьев, Д. Е. (2008) · CyberLeninK (CyberLeninka)
COPD makes CHIP less indeterminate
Huls, G. A. (2022) · Blood · doi:10.1182/blood.2021013966
Gillis, N., Moscinski, L. C., & Padron, E. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_57 · Cited by 1
González‐Gil, C., Morgades, M., Lopes, T., Fuster‐Tormo, F., García-Chica, J., Zhao, R., Montesinos, P., Torrent, A., Díaz‐Beyá, M., Coll, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1377009/v1
Sperling, A. S., & Ebert, B. L. (2017) · Blood · doi:10.1182/blood-2017-05-786210
Faculty Opinions recommendation of Understanding intrinsic hematopoietic stem cell aging.
Méndez‐Ferrer, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737043526.793575345
Klonale Hämatopoese – Ursachen und klinische Implikationen
Burchert, A. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01388-8
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms
Xie, Z., Chen, E. C., Mendez, L., Komrokji, R. S., & Zeidan, A. M. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000656
EXABS-171-MDS Update on CHIP and CCUS
Weeks, L. D. (2023) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/s2152-2650(23)00310-5
Impact of clonal hematopoiesis in COVID-19 patients at high risk for adverse clinical outcomes
Smith, C., Burugula, B. B., Jones, M. A., Li, Q., Kitzman, J. O., & Wong, T. (2023) · Translational Medicine Communications · doi:10.1186/s41231-023-00155-7
Pietka, G., Lord, C. D., Matthias, G., Cheung, B. Y. Y., Atwal, S., Furtado, M., Cullis, J., Grey‐Davies, L., Narayanan, S., McGregor, A. K., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19377
Bonadies, N. (2024) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2024.19.136
Lawrence, E., Cooray, A., Kueh, A. J., Pál, M., Tai, L., Garnham, A. L., Suen, C. S. N. L. W., Vanyai, H. K., Gouil, Q. A., Lancaster, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.12.607467
Leddin, E. M. (2022) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc1944361
Jarabek, A., Davis, X. D., Oliver, M., Wang, Y., Chen, H., Bohannon, J. K., & Zinkel, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.08.674943
He, X., Jia, Z.-N., Wu, J.-Z., Lv, J., Liu, Z., Liu, L., Liu, R.-L., Yuan, K., Yang, K., Li, C.-C., et al. (2025) · Discover Medicine · doi:10.1007/s44337-025-00281-1
Sun, H., Ruijie, L., Cao, X., Wang, H., Ding, P., Ang, Y., & Guo, X. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02823-0
Smith, C., Burugula, B. B., Jones, M. A., Li, Q., Kitzman, J. O., & Wong, T. N. (2023) · Figshare · doi:10.6084/m9.figshare.24225240
Smith, C., Burugula, B. B., Jones, M. A., Li, Q., Kitzman, J. O., & Wong, T. N. (2024) · Figshare · doi:10.6084/m9.figshare.24225247
Dalle, I. A., Galimard, J., Poiré, X., Sanz, J. L. V., Huynh, A., Kröger, N. M., Wagner-Drouet, E., Burns, D., Eder, M., Lioure, B., et al. (2025) · Bone Marrow Transplantation · doi:10.1038/s41409-025-02765-1
Barton, J. C., & Barton, J. C. (2026) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2026.01.004
Lee, N. C. J., Miao, R., & Young, N. S. (2026) · Leukemia · doi:10.1038/s41375-026-02865-x
Bagacean, C. (2018) · theses.fr (ABES) · doi:10.70675/4409fbafz6d37z497cza3b9zf76d4e09d242
Modifications du microenvironnement cytokinique dans les leucémies aigües myéloïdes
Guermouche, H. (2021) · theses.fr (ABES) · doi:10.70675/e0e649a1z9428z4e58z93b3z0b5d7ec2fea8
Pegliasco, J. (2024) · theses.fr (ABES) · doi:10.70675/12ce08e6zd564z4165zaee7zd80d8186dafd
Counting the CHIPs: The High-Stakes Role of Clonal Hematopoiesis in Multiple Myeloma
Szalay, M., Strange, I. S., Banwell, K., Campana, S., Dass, A., Hej-Ali, S., Mohamed, H., & Khan, S. (2026) · Biomedicines · doi:10.3390/biomedicines14040899
Liquid biopsy for molecular profiling in cutaneous T-cell lymphoma: a pilot feasibility study
Sacknovitz, Y., Erem, A. S., Kent, J., Albitar, M. X., Feldman, T. A., Pro, B., Tolu, S. S., Gru, A. A., & Geskin, L. J. (2026) · Blood Neoplasia · doi:10.1016/j.bneo.2026.100245
Hematopoietic somatic mutations in atherosclerotic cardiovascular disease
Ramos-Neble, B. L., & Fuster, J. J. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120718
Papasavva, P. L., Dosunmu-Ogunbi, A. M., Oni, M. O., Kountouris, P., Makani, J., Zilfalil, B. A., Inusa, B. P. D., Archer, N. M., Lederer, C. W., Ahmad, H., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025018935
Powell, N., Cubbon, R. M., Bailey, M. A., Griffin, K. J., Roberts, L. D., & Cheng, C. W. (2026) · Vascular Medicine · doi:10.1177/1358863x261437058
Hasan, M., Durandeau, S., Thompson, I. R., Roussotte, H., Tsai, Y.-T., Seymen, N., Gerlevik, S., Bianchini, N., Alishah, K., Albuquerque, M. M., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02510-6
Ünsal, Ş. E. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1943135
Somatic Blood Mosaicism and Psychiatric Disease: Current Evidence and Causal Limits
Belbe, A.-A., Pîrlog, L.-M., Pilatec, A.-N., Militaru, M.-S., Iordănescu, I. I., & Cătană, A. (2026) · Genes · doi:10.3390/genes17101224
TET2-driven activation of AGO2 links epigenetic remodeling to myeloid commitment and leukemia
Lazarenkov, A., Valcárcel, G., Martínez-Moreno, A., Berenguer, C., López-Rubio, A. V., Obiols, M., Fontanet, C., Barbă, A., Rodríguez‐Sevilla, J. J., Stik, G., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee5701
Metadata
- Authors
- Buscarlet, M., Provost, S., Zada, Y. F., Barhdadi, A., Bourgoin, V., Lépine, G., Mollica, L., Szuber, N., Dubé, M.-P., & Busque, L.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Montreal Heart Institute (CA)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-08-10
- Volume
- 130
- Issue
- 6
- Pages
- 753-762
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2728241634
- Cited by
- 383
- References
- 50
- Citations by year
- 2026: 22 · 2025: 34 · 2024: 37 · 2023: 47 · 2022: 59 · 2021: 55 · 2020: 46 · 2019: 40 · 2018: 34 · 2017: 6
- FWCI
- 26.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Concordia University
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- DNMT3A, TET2, clonal hematopoiesis, somatic mutations, X-inactivation skewing, telomere length, epigenetic regulators, genetic susceptibility, mutational burden
- MeSH terms
- DNA Methyltransferase 3A, Age Factors, Aged, Aged, 80 and over, Aging, Blood Cell Count, Clone Cells, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, Female, Hematopoiesis, Humans, Male, Middle Aged, Mutation, Proto-Oncogene Proteins, Cohort Studies, Hematologic Neoplasms, Genetic Predisposition to Disease, Dioxygenases, X Chromosome Inactivation, High-Throughput Nucleotide Sequencing, Telomere Homeostasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
